DFG
ELV icon

Demars Financial Group’s Elevance Health ELV Stock Holding History

Demars Financial Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-516
Closed -$201K – 96
2025
Q2 		$201K Sell
516
-206,090
-100% -$82.9M 0.08% 85
2025
Q1 		$475K Buy
+206,606
New +$82.9M 0.01% 72

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Demars Financial Group's ELV Position: Q3 2025 in Review

Demars Financial Group sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 516 shares — an estimated $201K sold.

Demars Financial Group first reported a position in ELV in Q1 2025 and held it in 2 quarters. The position peaked at $475K in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Demars Financial Group reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Demars Financial Group sold 516 Elevance Health shares in Q3 2025, an estimated $201K.
  • Demars Financial Group first reported a position in Elevance Health in Q1 2025 and held it in 2 quarters.
  • Demars Financial Group's Elevance Health position peaked at $475K in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Demars Financial Group's 13F filing for Q3 2025, filed 30 Oct 2025.